SIBO Treatment: Antibiotics, Diet, and What to Expect

What antibiotics are used to treat SIBO?

Rifaximin is the antibiotic most commonly used for hydrogen-dominant SIBO, and the 2020 ACG Clinical Guideline on SIBO recommends it as first-line treatment 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Rifaximin as first-line treatment for hydrogen-dominant SIBO; neomycin combination for IMO; prokinetics and underlying-cause management for recurrence prevention; probiotics insufficient evidence; specialist-led evaluation.. It is minimally absorbed from the gut, meaning it acts locally in the intestine with low systemic side effects 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Rifaximin as first-line treatment for hydrogen-dominant SIBO; neomycin combination for IMO; prokinetics and underlying-cause management for recurrence prevention; probiotics insufficient evidence; specialist-led evaluation.. Course length and dosing are set by a gastroenterologist based on the breath test pattern, symptom severity, and whether this is a first or repeat course 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Rifaximin as first-line treatment for hydrogen-dominant SIBO; neomycin combination for IMO; prokinetics and underlying-cause management for recurrence prevention; probiotics insufficient evidence; specialist-led evaluation.. Rifaximin is a prescription medication and requires a clinician's evaluation — it cannot be obtained over the counter.

Methane-dominant SIBO — now often called intestinal methanogen overgrowth (IMO) — typically responds better to rifaximin combined with neomycin, because the methane-producing archaea are not as susceptible to rifaximin alone. The ACG guideline recognizes IMO as a distinct entity with distinct treatment 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Rifaximin as first-line treatment for hydrogen-dominant SIBO; neomycin combination for IMO; prokinetics and underlying-cause management for recurrence prevention; probiotics insufficient evidence; specialist-led evaluation..

The goal of antibiotic treatment is to reduce the bacterial load in the small intestine and restore a more normal microbial environment. Some clinicians also use herbal antimicrobial protocols as an alternative in selected patients, though the evidence base is substantially less robust than for rifaximin. Decisions about which approach to use should always be made with a gastroenterologist.

What happens if SIBO comes back after antibiotics?

Recurrence is one of the central challenges in SIBO management. Antibiotics can reduce bacterial populations in the small intestine, but if the underlying reason for overgrowth persists, bacteria return.

Common underlying contributors include:

• Impaired motility: The migrating motor complex (MMC) — a cleansing wave that sweeps bacteria out of the small intestine between meals — can be sluggish because of prior gut infections, diabetes, hypothyroidism, or medications (particularly opioids)
• Structural abnormalities: Adhesions from prior abdominal surgery, diverticula, or strictures that create stagnant pockets
• Reduced gastric acid: Stomach acid kills ingested bacteria before they reach the small bowel; reduced acid (including from chronic proton pump inhibitor use) can allow more bacteria to survive and migrate

A gastroenterologist evaluates for these underlying contributors as part of a comprehensive SIBO management plan. Prokinetic therapy to support gut motility, repeat antibiotic courses, and dietary strategies may all be part of long-term management 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Rifaximin as first-line treatment for hydrogen-dominant SIBO; neomycin combination for IMO; prokinetics and underlying-cause management for recurrence prevention; probiotics insufficient evidence; specialist-led evaluation..

What role does diet play in SIBO treatment?

Diet does not cure SIBO on its own — bacteria established in the small intestine cannot be starved out in a practical timeframe — but dietary changes can meaningfully reduce the fermentation substrate and help manage symptoms during and after antibiotic treatment.

Low-FODMAP diet: Limiting fermentable carbohydrates (FODMAPs — found in onions, garlic, wheat, legumes, dairy, and many fruits) reduces the substrate available for bacterial fermentation. A systematic review and meta-analysis found that a low-FODMAP diet significantly reduced global IBS symptoms and bloating compared with control diets 2Ref 2van Lanen AS, de Bree A, Greyling A (2021).Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis.Low-FODMAP diet significantly reduces global IBS/fermentation symptoms vs control diet — rationale for its use as a symptom-management adjunct during SIBO treatment.. Because the symptoms of SIBO and IBS often overlap, and because many SIBO patients also meet IBS criteria, this approach is frequently used during active SIBO treatment to reduce discomfort. The low-FODMAP diet is best used as a short-term strategy with guidance from a registered dietitian rather than as an indefinite restriction.

Spacing meals: Eating three structured meals per day with at least 4–5 hours between them (avoiding constant snacking) allows the migrating motor complex to perform its cleansing work between meals — one of the body's own mechanisms for preventing small bowel bacterial buildup.

Avoiding alcohol and high-sugar beverages during treatment further reduces fermentation load.

What about probiotics for SIBO?

Probiotics are a common question in SIBO, and the evidence is mixed. The 2020 ACG SIBO guideline found insufficient evidence to recommend probiotics as a primary SIBO treatment, and some practitioners note that adding live organisms during active overgrowth may not be helpful 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Rifaximin as first-line treatment for hydrogen-dominant SIBO; neomycin combination for IMO; prokinetics and underlying-cause management for recurrence prevention; probiotics insufficient evidence; specialist-led evaluation.. Most gastroenterologists suggest revisiting the role of probiotics after the bacterial overgrowth has been treated, rather than using them as primary therapy.

Why does working with a GI specialist matter?

Self-treating SIBO without a confirmed diagnosis is a common and expensive mistake. The symptoms of SIBO overlap substantially with IBS, celiac disease, and other functional GI conditions. Rifaximin requires a prescription, and identifying and managing the underlying cause of overgrowth is essential for lasting improvement 1Ref 1Pimentel M, Saad RJ, Long MD, Rao SSC (2020).ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.Rifaximin as first-line treatment for hydrogen-dominant SIBO; neomycin combination for IMO; prokinetics and underlying-cause management for recurrence prevention; probiotics insufficient evidence; specialist-led evaluation..

Gale does not provide GI specialty care directly, but can help you understand your symptoms, navigate a referral to a gastroenterologist, and support primary care needs alongside specialty treatment.